One of the most important modifiable risk factors is homocysteine (HCY) (with a molecular weight of 135.2 DL). Homocysteine is a sulfur-containing amino acid that is produced during methionine metabolism and converted to cysteine and methionine via the Beta Synthase/Tetrahydrofolate Reductase/MethyI/Cystathionine enzymes during this metabolism. High levels of homocysteine in the blood can directly damage the lining of coronary arteries and are likely to cause atheroma, and expand formation of blood clots (
1). If the production of homocysteine increases or its metabolism is disrupted, its concentration increases in the cell and it enters extracellular fluids and provides the basis for the emergence of coronary artery disease (
2). High levels of homocysteine in the blood plasma can cause atherosclerosis in three ways: damage to the interior arterial wall, interference with blood clotting agents, and oxidation of low density lipoproteins (
3). Homocysteine along with TNF-α has a cellular damage effect by creating free radicals and as an inducer of apoptosis (scheduled or physiologic cell death) (
3). Clinical studies suggest that the increase in homocysteine in the amount of 5 micromoles per liter is similar to an increase in total cholesterol of 20 mg/dL. Many studies have shown that the relationship between total homocysteine levels and atherosclerosis is even stronger than the association between atherosclerosis and cholesterol (
4,
5). Homocysteine catabolism disorders cause its accumulation in the bloodstream and effectively initiate inflammatory and atherosclerotic processes (
6). One of the mechanisms through which homocysteine makes its pathologic effects is the increase in oxidative stress that may be produced for other causes, including physical activity in cells (
2). In other words, homocysteine is self-oxidised in plasma, thereby exacerbating oxidative stress by elevating production of reactive oxygen species that causes damage to endothelial cells and LDL oxidation (
6). Several factors affect the concentration of serum total tHCY homocysteine, including genetics, smoking, hypertension, creatine levels, total cholesterol and serum protein, and nutritional factors such as vitamin B12, B6, and folate deficiencies (
1).